Author | Year | Reference methods | Number of patients | Eradicated patients | Sensitivity (%) | Specificity (%) | |||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Histology | RUT | UBT | Serology | Culture | |||||||||
Corpus | Antrum | Corpus | Antrum | Corpus | Antrum | ||||||||
Yagi et al. [6] | 2002 | √ | √ | √ | √ |  |  | √ | √ | 557 | Unknown | 93.8 | 96.2 |
Nakayama et al. [8] | 2004 | √ | √ | √ | √ | √ | √ |  |  | 52 | Excluded | 93.5 | 100 |
Anagnostopoulos et al. [9] | 2007 | √ | √ | √ | √ |  |  |  |  | 95 | Unknown | 92.8 | 100 |
Machado et al. [10] | 2008 |  | √ |  | √ |  |  |  |  | 99 | Excluded in 12 months | 88.1 | 96.9 |
Gonen et al. [11] | 2009 | √ | √ | √ | √ |  |  |  |  | 129 | Excluded | 82.8 | 85.7 |
Yan et al. [15] | 2010 | √ |  | √ |  |  |  |  |  | 112 | Excluded | 66.7 | 100 |
Hidaka et al. [12] | 2010 | √ | √ |  |  | √ | √ |  |  | 87 | Excluded | 86.7 | 100 |
Cho et al. [13] | 2013 | √ | √ | √ | √ |  |  |  |  | 617 | Excluded | 89.1 | 93.3 |
Kato et al. [14] | 2013 | √ |  |  |  |  |  |  |  | 275 | Excluded | 48.0 | 93.6 |
Tongtawee et al. [16] | 2015 | √ |  | √ |  |  |  |  |  | 200 | Excluded in 2 months | 53.0 | 100 |
Garces-Duran et al. [17] | 2019 | √ | √ | √ | √ |  |  |  |  | 140 | Included | 49.0 | 100 |
Yuan et al.* | 2020 | √ |  |  |  |  |  |  |  | 165 | Included | 51.4 | 96.7 |